PortfoliosLab logoPortfoliosLab logo
SCLX vs. MDCX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SCLX vs. MDCX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Scilex Holding Company (SCLX) and Medicus Pharma Ltd (MDCX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SCLX achieves a -12.26% return, which is significantly higher than MDCX's -82.01% return.


SCLX

1D
0.98%
1M
-14.66%
6M
25.63%
YTD
-12.26%
1Y
-20.18%
3Y*
-61.16%
5Y*
-50.18%
10Y*
ALL TIME*
-47.40%

MDCX

1D
4.80%
1M
-33.89%
6M
-76.87%
YTD
-82.01%
1Y
-89.29%
3Y*
5Y*
10Y*
ALL TIME*
-75.77%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$505.47K$499.43K$773.71K
$729.88K$1.72M$1.09M

SCLX vs. MDCX - Yearly Performance Comparison


2026 (YTD)20252024
SCLX
Scilex Holding Company
-12.26%-18.25%-42.38%
MDCX
Medicus Pharma Ltd
-82.01%-37.04%-21.61%

Correlation

The correlation between SCLX and MDCX is 0.11, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.11

Correlation (All Time)
Calculated using the full available price history since Nov 14, 2024

0.07

Fundamentals

Market Cap

SCLX:

$56.59M

MDCX:

$6.07M

EPS

SCLX:

-$35.56

MDCX:

-$1.92

Total Revenue (TTM)

SCLX:

$30.25M

MDCX:

$0.00

Gross Profit (TTM)

SCLX:

$18.07M

MDCX:

$0.00

EBITDA (TTM)

SCLX:

-$352.83M

MDCX:

-$36.18M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SCLX vs. MDCX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

SCLX
SCLX Risk / Return Rank: 4141
Overall Rank
SCLX Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
SCLX Sortino Ratio Rank: 4848
Sortino Ratio Rank
SCLX Omega Ratio Rank: 4646
Omega Ratio Rank
SCLX Calmar Ratio Rank: 3636
Calmar Ratio Rank
SCLX Martin Ratio Rank: 3838
Martin Ratio Rank

MDCX
MDCX Risk / Return Rank: 88
Overall Rank
MDCX Sharpe Ratio Rank: 1313
Sharpe Ratio Rank
MDCX Sortino Ratio Rank: 88
Sortino Ratio Rank
MDCX Omega Ratio Rank: 88
Omega Ratio Rank
MDCX Calmar Ratio Rank: 33
Calmar Ratio Rank
MDCX Martin Ratio Rank: 77
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

SCLX vs. MDCX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Scilex Holding Company (SCLX) and Medicus Pharma Ltd (MDCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SCLXMDCXDifference
Sharpe ratioReturn per unit of total volatility

+0.52

Sortino ratioReturn per unit of downside risk

+1.95

Omega ratioGain probability vs. loss probability

1.07

0.83

+0.24

Calmar ratioReturn relative to maximum drawdown

-0.25

-0.98

+0.73

Martin ratioReturn relative to average drawdown

-0.35

-1.45

+1.10

SCLX vs. MDCX - Sharpe Ratio Comparison

The current SCLX Sharpe Ratio is -0.18, which is higher than the MDCX Sharpe Ratio of -0.70. The chart below compares the historical Sharpe Ratios of SCLX and MDCX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SCLX vs. MDCX - Drawdown Comparison

The maximum SCLX drawdown since its inception was -99.23%, roughly equal to the maximum MDCX drawdown of -96.62%. Use the drawdown chart below to compare losses from any high point for SCLX and MDCX.


Loading charts...

Drawdown Indicators


SCLXMDCXDifference

Max Drawdown

Largest peak-to-trough decline

-99.23%

-96.62%

-2.61%

Max Drawdown (1Y)

Largest decline over 1 year

-80.27%

-90.62%

+10.35%

Max Drawdown (3Y)

Largest decline over 3 years

-98.19%

Max Drawdown (5Y)

Largest decline over 5 years

-99.23%

Current Drawdown

Current decline from peak

-97.93%

-96.46%

-1.47%

Average Drawdown

Average peak-to-trough decline

-57.92%

-60.11%

+2.19%

Ulcer Index

Depth and duration of drawdowns from previous peaks

57.55%

61.30%

-3.75%

Volatility

SCLX vs. MDCX - Volatility Comparison

Scilex Holding Company (SCLX) and Medicus Pharma Ltd (MDCX) have volatilities of 31.96% and 33.61%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SCLXMDCXDifference

Volatility (1M)

Calculated over the trailing 1-month period

31.96%

33.61%

-1.65%

Volatility (6M)

Calculated over the trailing 6-month period

77.60%

123.42%

-45.82%

Volatility (1Y)

Calculated over the trailing 1-year period

114.80%

126.72%

-11.92%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

113.52%

130.72%

-17.20%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

109.13%

130.72%

-21.59%

Dividends

SCLX vs. MDCX - Dividend Comparison

Neither SCLX nor MDCX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

SCLX vs. MDCX - Financials Comparison

This section allows you to compare key financial metrics between Scilex Holding Company and Medicus Pharma Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


SCLX and MDCX have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MDCX has higher volatility (33.61%) compared to SCLX (31.96%). In terms of maximum drawdown, SCLX dropped -99.23% vs MDCX's -96.62%.

SCLX currently has the higher Sharpe Ratio (-0.18 vs -0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SCLX and MDCX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer